Integrated Diagnostics (UK) Price on December 23, 2024
IDHC Stock | 0.45 0.02 4.65% |
Below is the normalized historical share price chart for Integrated Diagnostics Holdings extending back to May 06, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Integrated Diagnostics stands at 0.45, as last reported on the 23rd of December, with the highest price reaching 0.45 and the lowest price hitting 0.45 during the day.
If you're considering investing in Integrated Stock, it is important to understand the factors that can impact its price. Integrated Diagnostics appears to be abnormally volatile, given 3 months investment horizon. Integrated Diagnostics holds Efficiency (Sharpe) Ratio of 0.12, which attests that the entity had a 0.12% return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Integrated Diagnostics, which you can use to evaluate the volatility of the firm. Please utilize Integrated Diagnostics' Downside Deviation of 4.26, risk adjusted performance of 0.1021, and Market Risk Adjusted Performance of 1.93 to validate if our risk estimates are consistent with your expectations.
Total Stockholder Equity is likely to drop to about 2.4 B in 2024. Common Stock Total Equity is likely to drop to about 917.7 M in 2024. Integrated Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 0.3687 | 50 Day MA 0.4378 | Beta 0.454 |
Integrated |
Sharpe Ratio = 0.1198
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | IDHC | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
3.84 actual daily | 34 66% of assets are more volatile |
Expected Return
0.46 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Integrated Diagnostics is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Integrated Diagnostics by adding it to a well-diversified portfolio.
Price Book 4.7697 | Enterprise Value Ebitda 7.7922 | Price Sales 0.0551 | Shares Float 266.4 M | Wall Street Target Price 0.544 |
Integrated Diagnostics Valuation on December 23, 2024
It is possible to determine the worth of Integrated Diagnostics on a given historical date. On December 23, 2024 Integrated was worth 0.45 at the beginning of the trading date compared to the closed value of 0.45. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Integrated Diagnostics stock. Still, in general, we apply an absolute valuation method to find Integrated Diagnostics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Integrated Diagnostics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Integrated Diagnostics' related companies.
Open | High | Low | Close | Volume | |
0.45 | 0.45 | 0.45 | 0.45 | 2.00 | |
12/23/2024 | 0.45 | 0.45 | 0.45 | 0.45 | 0.00 |
Backtest Integrated Diagnostics | | | Integrated Diagnostics History | | | Integrated Diagnostics Valuation | Previous |
Integrated Diagnostics Trading Date Momentum on December 23, 2024
On December 23 2024 Integrated Diagnostics Holdings was traded for 0.45 at the closing time. The highest price during the trading period was 0.45 and the lowest recorded bid was listed for 0.45 . There was no trading activity during the period 0.0. Lack of trading volume on December 23, 2024 did not cause price change. The trading delta at closing time to the current price is 0.00% . |
Integrated Diagnostics Fundamentals Correlations and Trends
By evaluating Integrated Diagnostics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Integrated Diagnostics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Integrated financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Integrated Diagnostics Stock history
Integrated Diagnostics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Integrated is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Integrated Diagnostics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Integrated Diagnostics stock prices may prove useful in developing a viable investing in Integrated Diagnostics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 540 M | 480 M | |
Net Income Applicable To Common Shares | 1.6 B | 1.7 B |
Integrated Diagnostics Stock Technical Analysis
Integrated Diagnostics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Integrated Diagnostics Period Price Range
Low | December 23, 2024
| High |
0.00 | 0.00 |
Integrated Diagnostics Holdings cannot be verified against its exchange. Please verify the symbol is currently traded on London Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Integrated Diagnostics December 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Integrated Diagnostics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Integrated Diagnostics shares will generate the highest return on investment. By undertsting and applying Integrated Diagnostics stock market strength indicators, traders can identify Integrated Diagnostics Holdings entry and exit signals to maximize returns
Integrated Diagnostics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Integrated Diagnostics' price direction in advance. Along with the technical and fundamental analysis of Integrated Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Integrated to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.1021 | |||
Jensen Alpha | 0.4376 | |||
Total Risk Alpha | 0.336 | |||
Sortino Ratio | 0.0988 | |||
Treynor Ratio | 1.92 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Integrated Stock Analysis
When running Integrated Diagnostics' price analysis, check to measure Integrated Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Diagnostics is operating at the current time. Most of Integrated Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integrated Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Diagnostics' price. Additionally, you may evaluate how the addition of Integrated Diagnostics to your portfolios can decrease your overall portfolio volatility.